Literature DB >> 3965550

Update on some epidemiologic features of intermittent claudication: the Framingham Study.

W B Kannel, D L McGee.   

Abstract

During 26 years of surveillance of the Framingham Study Cohort of 5,209 subjects, 176 men and 119 women developed occlusive peripheral arterial disease manifested as intermittent claudication (IC). The incidence increased sharply with age until the age of 75, with about a twofold male predominance at all ages. An incidence of IC comparable to that of angina pectoris was obtained ten years later in life than for angina pectoris. Cigarette smoking, impaired glucose tolerance, and hypertension were powerful predisposing factors. Impaired glucose tolerance was a greater risk in women than in men, and glycosuria carried a greater risk than other indicators of impaired glucose tolerance. Cigarette smoking had about the same impact in men and women, approximately doubling the risk, and the impact was discernible into advanced age. Hypertension increased risk 2.5- to fourfold, respectively, in men and women. A low vital capacity was associated with a substantial excess risk. Electrocardiographic evidence of left ventricular hypertrophy predicted IC in both sexes. Serum cholesterol, relative weight, and hematocrit were weak risk factors. A risk profile made up of the major cardiovascular risk factors was better for predicting IC than for predicting coronary heart disease. Mortality was increased two- to fourfold in men and women, respectively, mainly because of coexistent cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3965550     DOI: 10.1111/j.1532-5415.1985.tb02853.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  85 in total

Review 1.  Pharmacological treatment of patients with peripheral arterial disease.

Authors:  Chin K Kim; Carsten M Schmalfuss; Richard S Schofield; David S Sheps
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  Current strategies in the diagnosis and management of lower extremity peripheral vascular disease.

Authors:  T J Wilt
Journal:  J Gen Intern Med       Date:  1992 Jan-Feb       Impact factor: 5.128

3.  Approach to lipid therapy in the patient with atherosclerotic vascular disease.

Authors:  Reena L Pande
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

Review 4.  Peripheral arterial disease in diabetes: is there a role for genetics?

Authors:  Arabindra B Katwal; Ayotunde O Dokun
Journal:  Curr Diab Rep       Date:  2011-06       Impact factor: 4.810

Review 5.  Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: insights from the Framingham Study.

Authors:  William B Kannel; Philip A Wolf
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

6.  Symptomatic peripheral arterial disease: the value of a validated questionnaire and a clinical decision rule.

Authors:  Bianca Lw Bendermacher; Joep Aw Teijink; Edith M Willigendael; Marie-Louise Bartelink; Harry R Büller; Ron Jg Peters; Jelis Boiten; Machteld Langenberg; Martin H Prins
Journal:  Br J Gen Pract       Date:  2006-12       Impact factor: 5.386

7.  Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men.

Authors:  Michel M Joosten; Jennifer K Pai; Monica L Bertoia; Eric B Rimm; Donna Spiegelman; Murray A Mittleman; Kenneth J Mukamal
Journal:  JAMA       Date:  2012-10-24       Impact factor: 56.272

8.  Diabetic foot wounds in haemodialysis patients: 2-year outcome after percutaneous transluminal angioplasty and minor amputation.

Authors:  Kyoichi Matsuzaki; Akira Miyamoto; Naohiro Hakamata; Masahiro Fukuda; Yasutaka Yamauchi; Takako Akita; Ryoji Kuhara; Shingo Tezuka
Journal:  Int Wound J       Date:  2012-10-24       Impact factor: 3.315

Review 9.  Evidence-based management of peripheral vascular disease.

Authors:  Nicolas W Shammas; Eric J Dippel
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

Review 10.  Inpatient Glycemic Management of Non-cardiac CVD: Focus on Stroke and PVD.

Authors:  Estelle Everett; Nestoras Mathioudakis
Journal:  Curr Diab Rep       Date:  2018-06-16       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.